Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma

淋巴瘤 弥漫性大B细胞淋巴瘤 医学 美罗华 免疫组织化学 病理 内科学 胃肠病学
作者
Tasuku Kawano,Yuta Tsuyuki,Yuka Suzuki,Kazuyuki Shimada,Seiichi Kato,Taishi Takahara,Mayuko Mori,Masato Nakaguro,Ayako Sakakibara,Shigeo Nakamura,Akira Satou
出处
期刊:The American Journal of Surgical Pathology [Ovid Technologies (Wolters Kluwer)]
卷期号:45 (12): 1606-1615 被引量:8
标识
DOI:10.1097/pas.0000000000001809
摘要

Primary adrenal diffuse large B-cell lymphoma (PA-DLBCL) is rare. We investigate 23 Japanese patients with PA-DLBCL to understand the clinicopathologic features and biological behavior of this disease. The 17 males and 6 females had a median age of 74 years (range: 40 to 86 y). Tumor cells harbored Epstein-Barr virus–encoded small RNA (EBER) in 9 (39%) samples, including samples from the 2 patients with methotrexate-associated B-cell lymphoproliferative disorder. Programmed cell death ligand 1 (PD-L1) expression was detected in tumor cells of 6 (26%) samples, including 1 EBER + and 5 EBER − samples. Four (17%) patients exhibited an intravascular proliferating pattern, and all 4 patient samples showed positive staining for PD-L1 in tumor cells. Among those patients, 3 showed intravascular proliferating pattern accompanied by a diffuse extravascular proliferation of tumor cells, and 1 patient was diagnosed with intravascular large B-cell lymphoma. We divided the 23 patients into 3 groups: EBER + (n=9, 39%), EBER − PD-L1 + (n=5, 22%), and EBER − PD-L1 − (n=9, 39%). A comparison of the outcomes among the 3 groups showed significant differences in overall survival ( P =0.034). The EBER + group had the worst prognosis, and the EBER − PD-L1 − group had the best prognosis. We also compared the outcomes among the 3 groups that received rituximab-containing chemotherapies. Both the overall survival and progression-free survival were significantly different among these groups ( P <0.001 and P =0.002, respectively). In conclusion, we evaluated 3 types of PA-DLBCL and found that each had unique clinical, pathologic, and prognostic features. Our results suggested that immune senescence, iatrogenic immunodeficiency, and immune evasion contribute to the development of PA-DLBCL.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
禾日青完成签到,获得积分10
1秒前
卷心菜完成签到,获得积分10
1秒前
4秒前
马海鑫完成签到,获得积分10
4秒前
5秒前
ericzhouxx完成签到,获得积分10
5秒前
7秒前
岛err发布了新的文献求助10
9秒前
9秒前
小蘑菇应助ericzhouxx采纳,获得10
9秒前
云辞忧完成签到,获得积分10
11秒前
搜集达人应助知性的笑槐采纳,获得10
12秒前
Rrr发布了新的文献求助30
12秒前
科研牛马发布了新的文献求助10
12秒前
陈敏完成签到,获得积分10
14秒前
15秒前
Lee完成签到 ,获得积分10
16秒前
等待的代容完成签到,获得积分10
16秒前
17秒前
18秒前
直率晓灵完成签到,获得积分10
18秒前
科研通AI2S应助王梓磬采纳,获得10
19秒前
SciGPT应助yikun采纳,获得20
20秒前
22秒前
等待的觅珍完成签到,获得积分10
24秒前
天天快乐应助yaoyaoyao采纳,获得10
24秒前
哇咔咔发布了新的文献求助10
25秒前
SciGPT应助wg采纳,获得10
26秒前
小程同学发布了新的文献求助10
27秒前
哈哈哈发布了新的文献求助20
27秒前
开心黄豆完成签到,获得积分10
29秒前
29秒前
adam完成签到,获得积分10
29秒前
不配.应助IAMXC采纳,获得10
30秒前
干净的翠琴完成签到 ,获得积分10
31秒前
Jasper应助科研通管家采纳,获得10
31秒前
赘婿应助科研通管家采纳,获得10
31秒前
火焰向上发布了新的文献求助10
31秒前
烟花应助科研通管家采纳,获得10
32秒前
酷波er应助科研通管家采纳,获得10
32秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3143741
求助须知:如何正确求助?哪些是违规求助? 2795245
关于积分的说明 7813862
捐赠科研通 2451235
什么是DOI,文献DOI怎么找? 1304371
科研通“疑难数据库(出版商)”最低求助积分说明 627221
版权声明 601413